Annual Cash & Cash Equivalents
$38.11 M
-$436.00 K-1.13%
April 30, 2024
Summary
- As of February 8, 2025, CDMO annual cash & cash equivalents is $38.11 million, with the most recent change of -$436.00 thousand (-1.13%) on April 30, 2024.
- During the last 3 years, CDMO annual cash & cash equivalents has fallen by -$131.81 million (-77.57%).
- CDMO annual cash & cash equivalents is now -77.57% below its all-time high of $169.91 million, reached on April 30, 2021.
Performance
CDMO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$33.41 M
+$34.00 K+0.10%
October 31, 2024
Summary
- As of February 8, 2025, CDMO quarterly cash and cash equivalents is $33.41 million, with the most recent change of +$34.00 thousand (+0.10%) on October 31, 2024.
- Over the past year, CDMO quarterly cash and cash equivalents has increased by +$34.00 thousand (+0.10%).
- CDMO quarterly cash and cash equivalents is now -80.33% below its all-time high of $169.91 million, reached on April 30, 2021.
Performance
CDMO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CDMO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.1% | +0.1% |
| 3 y3 years | -77.6% | -73.5% |
| 5 y5 years | +17.8% | -73.5% |
CDMO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -77.6% | at low | -77.7% | +34.2% |
| 5 y | 5-year | -77.6% | +17.8% | -80.3% | +34.2% |
| alltime | all time | -77.6% | +2141.5% | -80.3% | >+9999.0% |
Avid Bioservices Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $33.41 M(+0.1%) |
| Jul 2024 | - | $33.38 M(-12.4%) |
| Apr 2024 | $38.11 M(-1.1%) | $38.11 M(+24.1%) |
| Jan 2024 | - | $30.71 M(-2.3%) |
| Oct 2023 | - | $31.42 M(+26.2%) |
| Jul 2023 | - | $24.90 M(-35.4%) |
| Apr 2023 | $38.54 M(-69.5%) | $38.54 M(-35.7%) |
| Jan 2023 | - | $59.92 M(-22.5%) |
| Oct 2022 | - | $77.29 M(-32.9%) |
| Jul 2022 | - | $115.14 M(-8.7%) |
| Apr 2022 | $126.17 M(-25.7%) | $126.17 M(-15.9%) |
| Jan 2022 | - | $149.96 M(-8.4%) |
| Oct 2021 | - | $163.68 M(+2.5%) |
| Jul 2021 | - | $159.69 M(-6.0%) |
| Apr 2021 | $169.91 M(+368.6%) | $169.91 M(+139.7%) |
| Jan 2021 | - | $70.89 M(+98.8%) |
| Oct 2020 | - | $35.66 M(+26.4%) |
| Jul 2020 | - | $28.21 M(-22.2%) |
| Apr 2020 | $36.26 M(+12.1%) | $36.26 M(+18.2%) |
| Jan 2020 | - | $30.69 M(-9.6%) |
| Oct 2019 | - | $33.96 M(+17.3%) |
| Jul 2019 | - | $28.94 M(-10.5%) |
| Apr 2019 | $32.35 M(-23.5%) | $32.35 M(+16.5%) |
| Jan 2019 | - | $27.76 M(-15.1%) |
| Oct 2018 | - | $32.69 M(-12.8%) |
| Jul 2018 | - | $37.48 M(-11.3%) |
| Apr 2018 | $42.27 M(-9.7%) | $42.27 M(+135.6%) |
| Jan 2018 | - | $17.94 M(-35.3%) |
| Oct 2017 | - | $27.73 M(-25.6%) |
| Jul 2017 | - | $37.26 M(-20.4%) |
| Apr 2017 | $46.80 M(-23.8%) | $46.80 M(+12.7%) |
| Jan 2017 | - | $41.53 M(-15.3%) |
| Oct 2016 | - | $49.05 M(+11.0%) |
| Jul 2016 | - | $44.20 M(-28.0%) |
| Apr 2016 | $61.41 M(-9.7%) | $61.41 M(-9.0%) |
| Jan 2016 | - | $67.47 M(-6.3%) |
| Oct 2015 | - | $72.00 M(+22.0%) |
| Jul 2015 | - | $59.02 M(-13.2%) |
| Apr 2015 | $68.00 M(-12.2%) | $68.00 M(+23.1%) |
| Jan 2015 | - | $55.24 M(-14.3%) |
| Oct 2014 | - | $64.44 M(-12.0%) |
| Jul 2014 | - | $73.26 M(-5.5%) |
| Apr 2014 | $77.49 M(+120.1%) | $77.49 M(+22.7%) |
| Jan 2014 | - | $63.18 M(+42.2%) |
| Oct 2013 | - | $44.44 M(+6.8%) |
| Jul 2013 | - | $41.60 M(+18.2%) |
| Apr 2013 | $35.20 M(+95.2%) | $35.20 M(+34.1%) |
| Jan 2013 | - | $26.25 M(+7.4%) |
| Oct 2012 | - | $24.44 M(+28.7%) |
| Jul 2012 | - | $18.99 M(+5.3%) |
| Apr 2012 | $18.03 M(-21.9%) | $18.03 M(-8.7%) |
| Jan 2012 | - | $19.76 M(+9.4%) |
| Oct 2011 | - | $18.05 M(+9.2%) |
| Jul 2011 | - | $16.54 M(-28.3%) |
| Apr 2011 | $23.07 M(+17.2%) | $23.07 M(-4.1%) |
| Jan 2011 | - | $24.07 M(+39.4%) |
| Oct 2010 | - | $17.27 M(-4.0%) |
| Jul 2010 | - | $17.98 M(-8.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2010 | $19.68 M(+96.5%) | $19.68 M(+16.9%) |
| Jan 2010 | - | $16.84 M(+23.8%) |
| Oct 2009 | - | $13.60 M(+6.4%) |
| Jul 2009 | - | $12.78 M(+27.6%) |
| Apr 2009 | $10.02 M(-33.8%) | $10.02 M(-7.7%) |
| Jan 2009 | - | $10.85 M(+32.2%) |
| Oct 2008 | - | $8.21 M(-17.6%) |
| Jul 2008 | - | $9.96 M(-34.2%) |
| Apr 2008 | $15.13 M(-5.7%) | $15.13 M(-24.6%) |
| Jan 2008 | - | $20.06 M(-23.2%) |
| Oct 2007 | - | $26.14 M(-14.7%) |
| Jul 2007 | - | $30.64 M(+90.9%) |
| Apr 2007 | $16.04 M(-6.6%) | $16.04 M(-20.2%) |
| Jan 2007 | - | $20.11 M(-14.0%) |
| Oct 2006 | - | $23.39 M(-17.9%) |
| Jul 2006 | - | $28.50 M(+65.9%) |
| Apr 2006 | $17.18 M(+75.0%) | $17.18 M(+9.7%) |
| Jan 2006 | - | $15.66 M(+31.6%) |
| Oct 2005 | - | $11.90 M(-27.8%) |
| Jul 2005 | - | $16.50 M(+68.0%) |
| Apr 2005 | $9.82 M(-34.0%) | $9.82 M(-6.0%) |
| Jan 2005 | - | $10.44 M(+1.1%) |
| Oct 2004 | - | $10.32 M(-13.6%) |
| Jul 2004 | - | $11.96 M(-19.7%) |
| Apr 2004 | $14.88 M(+374.5%) | $14.88 M(-5.4%) |
| Jan 2004 | - | $15.74 M(+39.6%) |
| Oct 2003 | - | $11.28 M(+35.5%) |
| Jul 2003 | - | $8.32 M(+165.3%) |
| Apr 2003 | $3.14 M(-48.3%) | $3.14 M(-20.2%) |
| Jan 2003 | - | $3.93 M(-40.6%) |
| Oct 2002 | - | $6.63 M(+175.1%) |
| Jul 2002 | - | $2.41 M(-60.3%) |
| Apr 2002 | $6.07 M(-4.0%) | $6.07 M(-45.4%) |
| Jan 2002 | - | $11.13 M(+71.7%) |
| Oct 2001 | - | $6.48 M(-5.6%) |
| Jul 2001 | - | $6.87 M(+8.6%) |
| Apr 2001 | $6.33 M(+53.2%) | $6.33 M(-24.2%) |
| Jan 2001 | - | $8.35 M(+115.1%) |
| Oct 2000 | - | $3.88 M(-69.5%) |
| Jul 2000 | - | $12.71 M(+207.6%) |
| Apr 2000 | $4.13 M(+72.1%) | $4.13 M(+53.0%) |
| Jan 2000 | - | $2.70 M(+350.0%) |
| Oct 1999 | - | $600.00 K(-62.5%) |
| Jul 1999 | - | $1.60 M(-33.3%) |
| Apr 1999 | $2.40 M(+41.2%) | $2.40 M(+1100.0%) |
| Jan 1999 | - | $200.00 K(-87.5%) |
| Oct 1998 | - | $1.60 M(-67.3%) |
| Jul 1998 | - | $4.90 M(+188.2%) |
| Apr 1998 | $1.70 M(-86.1%) | $1.70 M(-37.0%) |
| Jan 1998 | - | $2.70 M(-30.8%) |
| Oct 1997 | - | $3.90 M(-54.1%) |
| Jul 1997 | - | $8.50 M(-30.3%) |
| Apr 1997 | $12.20 M(+190.5%) | $12.20 M(+481.0%) |
| Jan 1997 | - | $2.10 M(-46.2%) |
| Oct 1996 | - | $3.90 M(-44.3%) |
| Jul 1996 | - | $7.00 M(+66.7%) |
| Apr 1996 | $4.20 M | $4.20 M(+61.5%) |
| Jan 1996 | - | $2.60 M |
FAQ
- What is Avid Bioservices annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Avid Bioservices?
- What is Avid Bioservices annual cash & cash equivalents year-on-year change?
- What is Avid Bioservices quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Avid Bioservices?
- What is Avid Bioservices quarterly cash and cash equivalents year-on-year change?
What is Avid Bioservices annual cash & cash equivalents?
The current annual cash & cash equivalents of CDMO is $38.11 M
What is the all time high annual cash & cash equivalents for Avid Bioservices?
Avid Bioservices all-time high annual cash & cash equivalents is $169.91 M
What is Avid Bioservices annual cash & cash equivalents year-on-year change?
Over the past year, CDMO annual cash & cash equivalents has changed by -$436.00 K (-1.13%)
What is Avid Bioservices quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CDMO is $33.41 M
What is the all time high quarterly cash and cash equivalents for Avid Bioservices?
Avid Bioservices all-time high quarterly cash and cash equivalents is $169.91 M
What is Avid Bioservices quarterly cash and cash equivalents year-on-year change?
Over the past year, CDMO quarterly cash and cash equivalents has changed by +$34.00 K (+0.10%)